Issue 19, 2013

Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer

Abstract

Magnetic nanoparticles represent one of the most advanced developments in the application of nanotechnology to human health. To date, their clinical application has been restricted to the diagnosis of hepatic lesions and lymph node metastasis but functionalization of these materials with biomolecules as targeting motifs, and the inclusion of therapeutic drugs in their composition, is certain to make a substantial impact within biomedicine. One of the diseases that could benefit from these advances is cancer, as early diagnosis and effective treatment are crucial for a patient's survival and quality of life. This review will examine the recent uses of magnetic particles in cancer diagnosis and treatment.

Graphical abstract: Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer

Article information

Article type
Review Article
Submitted
29 Apr 2013
First published
21 Jun 2013

Chem. Soc. Rev., 2013,42, 7816-7833

Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer

J. Gallo, N. J. Long and E. O. Aboagye, Chem. Soc. Rev., 2013, 42, 7816 DOI: 10.1039/C3CS60149H

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements